TuHURA Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $8.1M | $8.9M | $-4.3M | $6.4M | $-8.3M | $-2.4M | $-1.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | $16.7K | $10.3K | — | — | — | — | — |
| Stock-Based Compensation | $124.7K | $394.1K | $186.9K | $1.5M | $2.1M | $1.1M | $95.1K |
| Net Cash from Operating Activities | $-8.0M | $-5.1M | $-3.9M | $-4.0M | $-5.5M | $-578.0K | $-228.7K |
| Investing Activities | |||||||
| Capital Expenditures | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-21.0K | $-16.8K | — | — | — | $0 | $0 |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $8.5M | $9.6M | $847.8K | $2.5M | — | $7.5K | $0 |
| Net Change in Cash | $428.8K | $4.4M | $-3.0M | $-1.5M | $4.1M | $2.8K | $-9.4K |
| Free Cash Flow | — | — | — | — | — | — | — |